Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin
- 1Institute of Pharmacy, Pharmaceutical College of Henan University, Kaifeng, China
- 2School of Pharmacy and Chemical Engineering, Zhengzhou University of Industry Technology, Xinzheng, China
- 3Chinese Medical School, Hunan University of Chinese Medicine, Changsha, China
Keywords: berberine, doxorubicin, neutrophil phenotype, carcinogenesis, chemotherapeutic resistance
Citation: Zhang S, Zhou L, Zhang M, Wang Y, Wang M, Du J, Gu W, Kui F, Li J, Geng S and Du G (2020) Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin. Front. Pharmacol. 10:1658. doi: 10.3389/fphar.2019.01658
Received: 06 November 2019; Accepted: 17 December 2019;
Published: 29 January 2020; Retracted: 07 December 2023.
Edited by:
Jiangjiang Qin, Zhejiang Chinese Medical University, ChinaReviewed by:
Dan Shao, South China University of Technology, ChinaQiao Liu, Shandong University, China
†These authors have contributed equally to this work